1. Eli Lilly and Company. Treatment of Pervasive Developmental Disorders with NorepinephrineReuptake Inhibitors, WO2005/20975 A2, 2005.
2. aSchwarz Pharma, Ltd. ShortenedSynthesis Using Paraformaldehyde or Trioxanes, US8,115,028, 2012.
3. bMiteni, S. P. A.,Process for the Preparation of 3,5-bis(trifluoromethyl) benzylalcohol, WO2005/035472A1, 2005.
4. aHoffman LaRoche, Inc. Chloromethylation of BenzeneCompounds, US3,465,051, 1969.